Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Turcot syndrome 1Endometrial Neoplasms 1Carcinoma, Endometrioid 1

Interventions

Standard of Care 25Exercise 24Interviews as Topic 19Blood Specimen Collection 18Educational Status 13Methods 12Surgical Procedures, Operative 11Drug Therapy 11Surveys and Questionnaires 10Radiosurgery 10Specimen Handling 9Saline Solution 9Acupuncture Therapy 9Paclitaxel 8Early Intervention, Educational 8Therapeutics 7Radiotherapy 7Magnetic Resonance Spectroscopy 7Electroacupuncture 7Cryotherapy 7Resistance Training 6Preoperative Exercise 6Practice Guidelines as Topic 6Palliative Care 6Dexmedetomidine 6Control Groups 6Colonoscopy 6Carboplatin 6tislelizumab 5Sentinel Lymph Node Biopsy 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Not yet recruiting × Medroxyprogesterone Acetate × Clear all
NCT06549855 2024-08-12

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Peking University People's Hospital

Phase NA Not yet recruiting
10 enrolled
Gynecologic

Turcot syndrome, Endometrial Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡